Live Breaking News & Updates on Koch Thomas Von

Stay updated with breaking news from Koch thomas von. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Randall-michael-giuffre , Dimensional-fund-advisors , Nasdaq , Renaissance-technologies , Citadel-advisors , Catalyst-financial-partners , Diamedica-therapeutics-inc , Securities-exchange-commission , Diamedica-therapeutics , Get-free-report , Director-randall-michael-giuffre , Exchange-commission

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Growth in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […] ....

Randall-michael-giuffre , Catalyst-financial-partners , Dimensional-fund-advisors , Nasdaq , Citadel-advisors , Renaissance-technologies , Diamedica-therapeutics-inc , Securities-exchange-commission , Diamedica-therapeutics , Get-free-report , Koch-thomas-von , Director-randall-michael-giuffre

Insider Buying: DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Major Shareholder Acquires $4,999,999.20 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) major shareholder Koch Thomas Von bought 1,470,588 shares of DiaMedica Therapeutics stock in a transaction on Friday, June 23rd. The shares were acquired at an average price of $3.40 per share, for a total transaction of $4,999,999.20. Following the completion of the acquisition, the insider now owns 4,326,435 […] ....

Diamedica-therapeutics-inc , Securities-exchange-commission , Nasdaq , Citadel-advisors , Catalyst-financial-partners , Renaissance-technologies , Diamedica-therapeutics-company-profile , Diamedica-therapeutics , Free-report , Koch-thomas-von , Exchange-commission